Nano‐Enabled Postbiotics in Functional Foods: Stability Challenges, Gastrointestinal Fate, and Translational Perspectives
Authors:
- 11 November 2026
- journal article
- review article
- Published by Wiley in Comprehensive Reviews in Food Science and Food Safety
- Vol. 25 (6)
Abstract
The increasing demand for preventive and personalized nutrition has driven rapid growth in functional food development. These foods are designed not only to provide basic nutrition but also to deliver health‐promoting bioactive compounds at specific sites. Postbiotics comprise nonviable microbial cells, cell components, and microbial metabolites. They have emerged as promising alternatives to live probiotics because of their improved safety, stability, and well‐defined biological functions. These components can support epithelial barrier integrity, metabolic regulation, and immune modulation. However, their application in functional foods remains limited by poor stability, gastrointestinal (GI) degradation, food‐matrix interactions, and low bioavailability following oral administration. This review discusses the major physicochemical and biological barriers affecting postbiotic stability and functionality. These include thermal degradation, pH instability, enzymatic breakdown, food‐matrix interactions, and storage‐related losses. It also highlights nano‐enabled delivery systems for improving postbiotic delivery. The main systems include liposomes, polymeric nanoparticles, nanogels, nanoemulsions, and solid lipid nanoparticles. Among these, nanoemulsions may offer comparatively greater translational promise for food applications because of their established processing, scalability, and compatibility with liquid and semisolid food matrices. Although the suitability of nanoemulsions depends on postbiotic properties and remains constrained by interfacial instability, oxidation, and food‐matrix interactions. These systems can improve protection, controlled release, GI targeting, and epithelial uptake. However, regulatory uncertainty, scale‐up challenges, economic constraints, and limited clinical evidence continue to hinder practical application. Future progress will depend on standardized characterization methods, long‐term clinical validation, comprehensive safety assessment, scalable manufacturing, regulatory harmonization, and commercialization.Keywords
This publication has 143 references indexed in Scilit:
- Nanoparticles and Nanomaterials for Targeted Drug Delivery: An Updated ReviewRegenerative Engineering and Translational Medicine, 2026
- Nano/Micro‐Engineered Hydrogel Carriers for Sustainable Agriculture: Bridging Structural Form to Field PerformanceAdvanced Sustainable Systems, 2026
- Engineering Peptides for Oral Delivery: Structural Design, Barrier Modulation, and Emerging Therapeutic TechnologiesPeptide Science, 2026
- Inulin‐Butyrate Nanogel for Modulation of Gut Microbiome, Intestinal Barrier, and Regulatory T‐Cells in ColitisSmall, 2026
- Postbiotics in Functional Foods: Microbial Derivatives Shaping Health, Immunity and Next‐Generation NutritionFood Frontiers, 2025
- An Integrated Engineering Approach to Creating Health‐Modulating PostbioticsMolecular Nutrition & Food Research, 2025
- Medicine‐Food Plant Polysaccharides Modulate Diabetes and Diabetic Complications Through Maintaining Gut Function: A ReviewFood Frontiers, 2025
- Drug Delivery Strategies for the Lower GI Tract: A ReviewAdvanced Healthcare Materials, 2025
- Liposomal Encapsulation in Food Systems: A Review of Formulation, Processing, and ApplicationsFood Science & Nutrition, 2025
- A Review: Surface Engineering of Lipid‐Based Drug Delivery SystemsSmall, 2024